[HTML] scielo.br

[HTML][HTML] Does vancomycin administered at an empirical dose ensure coverage of pediatric patients against gram-positive pathogens?

FR Pires, SI Paula, AF Delgado… - Revista Brasileira de …, 2020 - SciELO Brasil
Objetivo: Investigar a efetividade da vancomicina contra Gram-positivos com concentração
inibitória mínima de 1mg/L em pacientes pediátricos com base na razão entre área sob a …
被引用次数：4 相关文章
[PDF] scienceopen.com

[PDF][PDF] Does vancomycin administered at an empirical dose ensure coverage of pediatric patients against gram-positive pathogens?

FR Pires, SI de Paula, M Júnior… - Rev Bras Ter …, 2020 - scienceopen.com
Objective: To investigate the vancomycin effectiveness against grampositive pathogens with
the minimum inhibitory concentration of 1mg/L in pediatric patients based on the area under …

Does vancomycin administered at an empirical dose ensure coverage of pediatric patients against gram-positive pathogens?

FR Pires, SI de Paula, AF Delgado… - Rev Bras Ter …, 2020 - SciELO Brasil
Does vancomycin administered at an empirical dose ensure coverage of pediatric patients
against gram-positive pathogens? Page 1 Rev Bras Ter Intensiva. 2020;32(3):391-397 …

Does vancomycin administered at an empirical dose ensure coverage of pediatric patients against grampositive pathogens?

F Ribeiro Pires, S Ivani de Paula… - Revista Brasileira …, 2020 - search.ebscohost.com
Objective: To investigate the vancomycin effectiveness against grampositive pathogens with
the minimum inhibitory concentration of 1mg/L in pediatric patients based on the area under …
[PDF] usp.br

[PDF][PDF] Does vancomycin administered at an empirical dose ensure coverage of pediatric patients against grampositive pathogens?

FR Pires, SI Paula, AF Delgado… - Revista Brasileira de …, 2020 - repositorio.usp.br
Objective: To investigate the vancomycin effectiveness against grampositive pathogens with
the minimum inhibitory concentration of 1mg/L in pediatric patients based on the area under …
[PDF] usp.br

[PDF][PDF] Does vancomycin administered at an empirical dose ensure coverage of pediatric patients against gram-positive pathogens?

FR Pires, SI de Paula, M Júnior… - Rev Bras Ter …, 2020 - observatorio.fm.usp.br
Objective: To investigate the vancomycin effectiveness against grampositive pathogens with
the minimum inhibitory concentration of 1mg/L in pediatric patients based on the area under …

Does vancomycin administered at an empirical dose ensure coverage of pediatric patients against gram-positive pathogens?

FR Pires, SI Paula, AF Delgado… - Revista Brasileira de …, 2020 - europepmc.org
Objective To investigate the vancomycin effectiveness against gram-positive pathogens with
the minimum inhibitory concentration of 1mg/L in pediatric patients based on the area under …

Does vancomycin administered at an empirical dose ensure coverage of pediatric patients against gram-positive pathogens?

FR Pires, SI de Paula, AF Delgado… - Revista Brasileira …, 2020 - pubmed.ncbi.nlm.nih.gov
Objective To investigate the vancomycin effectiveness against gram-positive pathogens with
the minimum inhibitory concentration of 1mg/L in pediatric patients based on the area under …
[HTML] scielo.br

[HTML][HTML] Does vancomycin administered at an empirical dose ensure coverage of pediatric patients against gram-positive pathogens?

FR Pires, SI Paula, AF Delgado… - Revista Brasileira de …, 2020 - SciELO Brasil
Objective: To investigate the vancomycin effectiveness against grampositive pathogens with
the minimum inhibitory concentration of 1mg/L in pediatric patients based on the area under …
[HTML] nih.gov

[HTML][HTML] Does vancomycin administered at an empirical dose ensure coverage of pediatric patients against gram-positive pathogens?

FR Pires, SI de Paula, AF Delgado… - Revista Brasileira de …, 2020 - ncbi.nlm.nih.gov
Objective To investigate the vancomycin effectiveness against gram-positive pathogens with
the minimum inhibitory concentration of 1mg/L in pediatric patients based on the area under …